These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 2731404

  • 1. The effect of cirrhosis on the steady-state pharmacokinetics of oral ciprofloxacin.
    Frost RW, Lettieri JT, Krol G, Shamblen EC, Lasseter KC.
    Clin Pharmacol Ther; 1989 Jun; 45(6):608-16. PubMed ID: 2731404
    [Abstract] [Full Text] [Related]

  • 2. Elimination of ciprofloxacin and three major metabolites and consequences of reduced renal function.
    Bergan T, Thorsteinsson SB, Rohwedder R, Scholl H.
    Chemotherapy; 1989 Jun; 35(6):393-405. PubMed ID: 2612228
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The distribution of ciprofloxacin and its metabolites in human plasma, pulmonary and bronchial tissues.
    Bacracheva N, Scholl H, Gerova Z, Chervenakov P, Dobrev P, Vlahov V.
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):352-6. PubMed ID: 1937996
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic and depletion studies of sarafloxacin after oral administration to eel (Anguilla anguilla).
    Ho SP, Cheng CF, Wang WS.
    J Vet Med Sci; 1999 May; 61(5):459-63. PubMed ID: 10379934
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of fluoroquinolones in hepatic failure.
    Montay G, Gaillot J.
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():61-7. PubMed ID: 2258353
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Assessment of bioequivalence of ciprofloxacin in healthy male subjects using HPLC.
    Khan MK, Khan MF.
    Pak J Pharm Sci; 2008 Jul; 21(3):299-306. PubMed ID: 18614429
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of ciprofloxacin in liver cirrhosis.
    Ruhnke M, Trautmann M, Borner K, Hopfenmüller W.
    Chemotherapy; 1990 Jul; 36(6):385-91. PubMed ID: 2292201
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
    Anadón A, Martínez-Larrañaga MR, Díaz MJ, Fernández-Cruz ML, Martínez MA, Frejo MT, Martínez M, Iturbe J, Tafur M.
    Am J Vet Res; 1999 Nov; 60(11):1377-82. PubMed ID: 10566812
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative bioequivalence and pharmacokinetics of ciprofloxacin in healthy male subjects.
    Khan MK, Khan MF.
    Pak J Pharm Sci; 2009 Jan; 22(1):1-7. PubMed ID: 19168412
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multiple-dose pharmacokinetics of rufloxacin in patients with cirrhosis.
    Triger DR, Granai F, Woodcock J, Wise R, Imbimbo BP.
    Hepatology; 1993 Oct; 18(4):847-52. PubMed ID: 8406358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.